Cargando…
Nanotechnology-Based siRNA Delivery Systems to Overcome Tumor Immune Evasion in Cancer Immunotherapy
Immune evasion is a common reason causing the failure of anticancer immune therapy. Small interfering RNA (siRNA), which can activate the innate and adaptive immune system responses by silencing immune-relevant genes, have been demonstrated to be a powerful tool for preventing or reversing immune ev...
Autores principales: | Deng, Kaili, Yang, Dongxue, Zhou, Yuping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315482/ https://www.ncbi.nlm.nih.gov/pubmed/35890239 http://dx.doi.org/10.3390/pharmaceutics14071344 |
Ejemplares similares
-
Utilizing RNA nanotechnology to construct negatively charged and ultrasound-responsive nanodroplets for targeted delivery of siRNA
por: Guo, Lu, et al.
Publicado: (2022) -
Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer
por: Zhou, Yue, et al.
Publicado: (2022) -
Triple Immunotherapy Overcomes Immune Evasion by Tumor in a Melanoma Mouse Model
por: Jallad, Mary-Ann N., et al.
Publicado: (2020) -
Targeted Delivery of siRNA
por: Oliveira, Sabrina, et al.
Publicado: (2006) -
Dendrimers for siRNA Delivery
por: Biswas, Swati, et al.
Publicado: (2013)